Sensitization against medical hyaluronidase in patients with confirmed hypersensitivity against hymenoptera species and its clinical implications
Authors:
- 15 July 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 191 (6) , 1000-1007
Abstract
Background: Hyaluronidase is an ubiquitous enzyme, present, among others, in hymenoptera venom and in medical formulations. The latter include use as an emergency treatment or to correct undesired outcomes of medical and aesthetic procedures using hyaluronic acid fillers. Objectives: By performing detailed allergy work-ups including skin-prick tests (SPTs) we investigated whether patients with a history of allergic reaction to hymenoptera venom are also sensitized to medical grade hyaluronidase. Methods: Ninety patients with a history of type-1 reaction to hymenoptera venom with and without a history of previous specific venom immunotherapy were included in the study. All underwent SPTs for medical hyaluronidase. All patients also underwent serological analysis for Api m2, the only commercially available IgE test for a hymenoptera hyaluronidase. Results: Of the 90 patients with previous type-1 reactions to hymenoptera venom hyaluronidase included in the study, 60 had undergone previous venom immunotherapy; 30 did not. The majority (73 of 90) were allergic to wasps, followed by honeybees (14 of 90) and three were allergic to both. Neither patients having undergone previous immunotherapy nor those allergic to bees showed positive SPTs to medical hyaluronidase. Of those with a wasp allergy and naïve to immunotherapy, over 20% (5 of 23) showed positive SPTs to medical hyaluronidase. Healthy controls (0 of 30) without previous allergic reactions to hymenoptera did not show positive SPTs to medical hyaluronidase. Conclusions: Sensitization to hyaluronidase is most common in wasp-allergic patients who have not had previous specific immunotherapy. As allergic reactions to medical hyaluronidase are reported to be scarce, this group is probably at the highest risk to develop anaphylaxis to medical hyaluronidase. While all patients with untreated anaphylaxis to hymenoptera venom should consult an allergy specialist, it is particularly important that those with untreated wasp allergies seek specialist advice before treatment with medical hyaluronidase is initiated.Keywords
Funding Information
- Department of Dermatology
- LMU
This publication has 24 references indexed in Scilit:
- Allergic Complications of Hyaluronidase Injection: Risk Factors, Treatment Strategies, and Recommendations for ManagementAesthetic Plastic Surgery, 2023
- Early ultrasound for diagnosis and treatment of vascular adverse events with hyaluronic acid fillersJournal of the American Academy of Dermatology, 2023
- A Scoping Review of Hyaluronidase Use in Managing the Complications of Aesthetic InterventionsAesthetic Plastic Surgery, 2022
- Nasal Filling in Plastic Surgery Practice: Primary Nasal Filling, Nasal Filling for Post-rhinoplasty Defects, Rhinoplasty After Hyaluronidase Injection in Dissatisfied Nasal Filling PatientsAesthetic Plastic Surgery, 2020
- Diagnostik der Hymenopterengiftallergie: aktuelle Konzepte und Entwicklungen mit besonderem Fokus auf die molekulare AllergiediagnostikAllergo Journal, 2017
- Hyaluronidase activity in the salivary glands of tabanid fliesInsect Biochemistry and Molecular Biology, 2016
- Reassessing the role of hyaluronidase in yellow jacket venom allergyJournal of Allergy and Clinical Immunology, 2010
- Injected Hyaluronidase Reduces Restylane-Mediated Cutaneous AugmentationArchives of Facial Plastic Surgery, 2005
- Protein components of fire ant venom (Solenopsis invicta)Toxicon, 1979
- USE OF HYALURONIDASE WITH LOCAL ANESTHESIA IN OPHTHALMOLOGYArchives of Ophthalmology (1950), 1949